期刊文献+

糖基化终末产物对大鼠肾系膜细胞胰岛素样生长因子-1表达的影响 被引量:2

Effects of advanced glycation end products on insulin-like growth factor-1 expression in rat mesangial cells
下载PDF
导出
摘要 目的:观察糖基化终末产物(AGEs)对大鼠肾系膜细胞胰岛素样生长因子-1(IGF-1)表达的影响及其与细胞外基质(ECM)成分含量的关系。方法:体外培养正常大鼠肾系膜细胞,分别用不同浓度(0、12.5、25.0、50.0、100.0和200.0mg·L^-1)糖基化牛血清白蛋白(AGEs)处理,相应浓度未经糖化的牛血清白蛋白(BSA)作为对照,ELISA法检测纤维连接蛋白(FN)和Ⅳ型胶原及IGF-1含量。结果:与相应浓度的BSA组比较,12.5~200.0mg·L^-1 AGEs组FN含量明显升高(P〈0.01),100.0~200.0mg·L^-1 AGEs组Ⅳ型胶原含量明显升高(P〈O.01),25.0~100.0mg·L^-1 AGEs组IGF-1蛋白含量明显升高(P〈0.01),200.0mg·L^-1 AGEs组IGF-1含量无明显变化。结论:AGEs引起的细胞外基质积聚可能在一定范围内与IGF-1上调有关。 Objective To investigate the effects of advanced glycation end products (AGEs) on insulin-like growth factor -1 (IGF-1) expression in rat mesangial cells and its relationship with extracellular matrix (ECM) accumulation. Methods Rat mesangial ceils were treated with AGEs-modified bovine serum albumin with different concentrations (0, 12.5 , 25.0 , 50.0 , 100.0 and 200.0 mg·L^-1), corresponding concentration native bovine serum albumin (BSA) as control. Fibrinectin, collagen IV and ICF-1 protein contents were detected by ELISA. Results Compared with those of corresponding concentration BSA group, FN contents in 12.5-- 200.0 mg ·L^-1 AGEs group increased significantly (P〈0.01); collagen IV contents in 100.0 200.0 mg·L^-1 AGEs group increased significantly (P〈0.01)~ IGF1 contents in 25.0--100.0 mg·L^-1AGEs group increased significantly (P〈0.01) ; and 200.0 mg ·L^-1 AGEs showed no promotion on IGF-1 expression. Conclusion ECM accumulation induced by AGEs is relevant to IGF-1 in a certain range.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2007年第1期54-56,共3页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金资助课题(39870312)
关键词 肾小球膜 糖基化终产物 高级 胰岛素样生长因子-Ⅰ 糖尿病肾病 glomerular mesangium~ glycosylation end products, advanced~ insulin-like growth factor- Ⅰ ;diabetic nephropathies
  • 相关文献

参考文献7

二级参考文献24

  • 1黄翠玲,李才,邓义斌,王丽娟,张秀云,赵丽艳.大黄对糖尿病大鼠肾组织非酶促糖基化的影响[J].中国糖尿病杂志,1996,4(2):103-106. 被引量:56
  • 2Schneider M, Wolf E, Hoeflich A, et al. Insulin - like growth factor-binding protein- 5:flexible player in the IGF system and effector on its own. J Endocr,2002,172(3 ) :423 - 440.
  • 3Linda L, Amy N, Liliane J, et al. Protection against diabetes - induced nephropathy in growth hormone receptor/binding protein gene- disrupted mice. Endocrinology,2000,141(1): 163 - 168.
  • 4John A, Alessandra L, Eliana P, et al. Modulation of growth hormone signal transduction in kidneys of streptozotocin - induced diabetic animals.Diabetes , 2002 , 51 (7) :2270 - 2281.
  • 5Nielsen B, Schrijvers B, Rasch R, et al. Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice. J Endocr,2002,172(3) :637 - 643.
  • 6Suzanne L, Reinier N, Ingrid E, et al. Connective tissue growth factor and IGF- I are produced by human renal fibroblasts and cooperatein the induction of collagen production by high glucose. Diabetes,2003,52( 12):2975 - 2983.
  • 7Ralph R, Franz S. New concepts: growth hormone, insulin - like growth factor- 1 and the kidney. Growth Hormone & IGF Research, 2004, 14(4) :270 - 276.
  • 8Wacharasindhu S,Srivuthana S,Aroonparkmongkol S.Insulin- like growth factors and binding protein in children with IDDM.J Med Assoc Thai,2002,85(1) :41 - 52.
  • 9Lupia E,Elliot SJ,Lenz O,et al. IGF- 1 decreases collagen degradation in diabetic NOD sangial cellsme: implications for diabetic nephropathy.Diabetes, 1999,48(8): 1638.
  • 10Bachael LA, Youssef S, Mark E, et al. Aminoguanidine ameliorates changes in the IGF system in experimental diabetic nephropathy.Nephrol Dia transp,2000,15(3) :347 - 354.

共引文献20

同被引文献24

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部